Islam Magalov

No ORCID on file · 6 papers in corpus · active 2008-2024

Study types

  • article 6

Condition tags

  • endometriosis 3
  • mesh:D004715 1
  • die_deep_infiltrating 1
  • adenomyosis 1
article 2024
FEATURES OF DOPPLER INDICATORS OF UTERINE BLOOD FLOW IN PATIENTS WITH ADENOMYOSIS
·doi:10.26724/2079-8334-2024-1-87-11-15
article 2018
ALTERNATIVE METHODS OF TREATMENT OF ENDOMETRIOSIS: RESVERATROL AND ITS COMBINATION WITH HORMONOTHERAPY
·doi:10.20333/2500136-2018-2-106-108

Красноярский государственный медицинский университет имени профессора В.Ф.Войно-

article 2017
ACTIVELY WORKING SUBSTANCE FROM THE GREEN TEA FOR THE TREATMENT OF ENDOMETRIOSIS AND UTERINE FIBROIDS. VIEW ON THE PROBLEM OF GERMAN AND RUSSIAN EXPERTS
·doi:10.20333/2500136-2017-6-31-39

, Z1022, 5 ,

article 2016
Resveratrol als Option bei Endometriose?
·doi:10.1007/s15013-016-0871-7
article 2011
Dienogest (DNG) in der Therapie der Endometriose Übersicht zur aktuellen Studienlage

Kurzfassung: Schon seit Jahren sind Gestagene in der Therapie der Endometriose etabliert. Dienogest (DNG), als „neues Gestagen“ der 19Nortestosteron-Gruppe propagiert, nimmt eine Sonderstellung ein. DNG zeigt eine relativ starke antiandroge…

article 2008
Co-Occurrence of Atypical Endometriosis, Subserous Uterine Leiomyomata, Sactosalpinx, Serous Cystadenoma and Bilateral Hemorrhagic Corpora Lutea in a Perimenopausal Adipose Patient Taking Tamoxifen (20 mg/Day) for Invasive Lobular Breast Cancer
Gynecologic and obstetric investigation ·doi:10.1159/000146085

BACKGROUND: For women taking tamoxifen, recent data strongly support the estrogen agonist role of tamoxifen as a causal factor for the increased risk of endometriosis, but also of leiomyomata, endometrial polyps, and endometrial hyperplasia…